X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-04-02 | INZY | Treco Douglas A | CEO | S - Sale+OE | $6.94 | -7,523 | 20,665 | -27% | -$52,210 | |||||
2023-08-01 | INZY | Pivotal Bioventure Partners Fund I, L.P. | Dir | P - Purchase | $4.80 | +833,333 | 1,571,741 | +113% | +$3,999,998 | ||||||
2023-08-01 | INZY | Hopfner Robert Lorne | Dir | P - Purchase | $4.80 | +833,333 | 1,571,741 | +113% | +$3,999,998 | ||||||
M | 2023-05-11 | INZY | Hopfner Robert Lorne | Dir | P - Purchase | $6.36 | +447,932 | 3,661,518 | +14% | +$2,849,998 | |||||
2023-03-29 | INZY | Hopfner Robert Lorne | Dir | P - Purchase | $4.54 | +344,592 | 3,213,586 | +12% | +$1,563,724 | ||||||
M | 2023-03-27 | INZY | Hopfner Robert Lorne | Dir | P - Purchase | $4.05 | +207,840 | 2,868,994 | +8% | +$841,063 | |||||
2022-12-15 | INZY | Bjarke Henric Bjorn | SVP, COO | P - Purchase | $1.39 | +21,500 | 105,441 | +26% | +$29,885 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |